# Articaine 4% Versus Lidocaine 2% for Local Anesthesia of MIH-affected Maxillary Molars

> **NCT05585112** · PHASE1,PHASE2 · COMPLETED · sponsor: **Tishreen University** · enrollment: 26 (actual)

## Conditions studied

- Molar Incisor Hypomineralisation

## Interventions

- **DRUG:** Lidocaine 2%
- **DRUG:** Articaine 4%

## Key facts

- **NCT ID:** NCT05585112
- **Lead sponsor:** Tishreen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-17
- **Primary completion:** 2022-12-05
- **Final completion:** 2022-12-25
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05585112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05585112, "Articaine 4% Versus Lidocaine 2% for Local Anesthesia of MIH-affected Maxillary Molars". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT05585112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*